Inflammatory mediator production in swine following endotoxin challenge with or without co-administration of dexamethasone

International Immunopharmacology

Volumn 3, Issue 4, 2003, Pages 571-579

  Myers, Michael J ^a   Farrell, Dorothy E ^a   Palmer, Douglas C ^a   Post, Lynn O ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Dexamethasone; Endotoxin challenge; Lipopolysaccharide

Indexed keywords

AUTACOID; BACTERIUM LIPOPOLYSACCHARIDE; DEXAMETHASONE; ENDOTOXIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NEOPTERIN; NITRIC OXIDE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; IMMUNITY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SWINE;

EID: 0037388879     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(03)00048-1     Document Type: Article

References (62)

1. Hammond J.M.J., Potgieter P.D. Immune modulation in sepsis. Kresina T.F. Immune modulating agents. 1998;301-343 Marcel Dekker, NY.
2. Myers M.J., Kawalek J.C. Effect of cytokines on drug metabolizing enzymes. Myers M.J., Murtaugh M.P. Cytokines in animal health and disease. 1995;235-259 Marcel Dekker, NY.
3. Morgan E.T. Regulation of cytochrome P450 by inflammatory mediators: why and how? Drug Metab. Dispos. 29:2001;207-212.
4. Post L.O., Farrell D.E., Cope C.V.et al. Influence of porcine Actinobacillus pleuropneumoniae (APP) infection and dexamethasone on the pharmacokinetic parameters of enrofloxacin. J. Pharmacol. Exp. Ther. 301:2001;217-222.
5. Post L.O., Farrell D.E., Cope C.V.et al. The effect of endotoxin and dexamethasone on enrofloxacin pharmacokinetic parameters in swine. J. Pharmacol. Exp. Ther. 304:2003;889-895.
6. Myers M.J., Farrell D.E., Baker J.D.et al. Endotoxin challenge differentially affects cytokine production and metabolic status of growing and finishing swine. Domest. Anim. Endocrinol. 17:1999;345-360.
7. Klosterhalfen B., Horstmann-Jungemann K., Vogel P.et al. Time course of various inflammatory mediators during recurrent endotoxemia. Biochem. Pharmacol. 43:1992;2103-2109.
8. Nakajima Y., Momotani E., Takahashi H.et al. Endogenous tumor necrosis factor (TNF) production and modification of pathological lesions in experimental Escherichia coli endotoxemia of piglets. Vet. Immunol. Immunopathol. 45:1995;45-54.
9. Webel D.M., Finck B.N., Baker D.H.et al. Time course of increased plasma cytokines, cortisol, and urea nitrogen in pigs following intraperitoneal injection of lipopolysaccharide. J. Anim. Sci. 75:1997;1514-1520.
10. Green L.C., Wanger D.A., Glogowsky J.et al. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal. Biochem. 126:1982;131-138.
11. Marchant A., Amraoui Z., Gueydan C.et al. Methylprednisolone differentially regulates IL-10 and tumour necrosis factor (TNF) production during murine endotoxaemia. Clin. Exp. Immunol. 106:1996;91-96.
12. van der Poll T., Barber A.E., Lowry S.F. Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia - a clinical research center study. J. Clin. Endocrinol. Metab. 81:1996;3604-3606.
13. Swain M.G., Appleyard C., Wallace J.et al. Endogenous glucocorticoids released during acute toxic liver injury enhance hepatic IL-10 synthesis and release. Am. J. Physiol. 276:1999;G199-G205.
14. Visser J., van Boxel-Dezaire A., Methorst D.et al. Differential regulation of interleukin-10 (IL-10) and IL-12 by glucocorticoids in vitro. Blood. 91:1998;4255-4264.
15. Fushimi T., Okayama H., Seki T.et al. Dexamethasone suppressed gene expression and production of interleukin-10 by human peripheral blood mononuclear cells and monocytes. Int. Arch. Allergy Immunol. 112:1997;13-18.
16. Frachimont D., Martens H., Hagelstein M.T.et al. Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J. Clin. Endocrinol. Metab. 84:1999;2834-2839.
17. Elenkov I.J., Papanicolaou D.A., Wilder R.L.et al. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc. Assoc. Am. Physicians. 108:1996;374-381.
18. Splichal I., Trebichavsky I., Muneta Y.et al. Early cytokine response of gnobiotic piglets to Salmonella enterica serotype Typhimurium. Vet. Res. 33:2002;291-297.
19. Hurme M., Siljander P., Anttila H. Regulation of interleukin-1 beta production by glucocorticoids in human monocytes: the mechanism of action depends on the activation signal. Biochem. Biophys. Res. Commun. 180:1991;1383-1389.
20. Kimberlin D.W., Willis S.A., McCracken G.H. Jr.et al. Protein synthesis-dependent induction of interleukin-1 beta by lipopolysaccharide is inhibited by dexamethasone via mRNA destabilization in human astroglial cells. J. Clin. Immunol. 15:1995;199-204.
21. Ulich T.R., Guo K.Z., Irwin B.et al. Endotoxin-induced cytokine gene expression in vivo: II. Regulation of tumor necrosis factor and interleukin-1 alpha/beta expression and suppression. Am. J. Pathol. 137:1990;1173-1185.
22. Faccioli L.H., Souza G.E., Cunha F.Q.et al. Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration "in vivo" by indirect mechanisms. Agents Actions. 30:1990;344-349.
23. Brown E.A., Dare H.A., Marsh C.B.et al. The combination of endotoxin and dexamethasone induces type II interleukin 1 receptor (IL-1r II) in monocytes: a comparison to interleukin 1 beta (IL-1 beta) and interleukin 1-receptor antagonist (IL-1ra). Cytokine. 8:1996;828-836.
24. Redl H., Schlag G., Ceska M.et al. Interleukin-8 release in baboon septicemia is partially dependent on tumor necrosis factor. J. Infect. Dis. 167:1993;1464-1466.
25. Koyama S., Sato E., Nomura H.et al. The potential of various lipopolysaccharides to release IL-8 and G-CSF. Am. J. Physiol., Lung Cell Mol. Physiol. 278:2000;L658-L666.
26. Pajkrt D., Camoglio L., Tiel-van Buul M.C.M.et al. Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration. J. Immunol. 158:1997;3971-3977.
27. van der Poll T., Jansen P.M., Montegut W.J.et al. Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. J. Immunol. 158:1997;1971-1975.
28. Harada A., Sekido S., Kuno K.et al. Expression of recombinant rabbit IL-8 in Escherichia coli and establishment of the essential involvement of IL-8 in recruiting neutrophils into lipopolysaccharide-induced inflammatory site of rabbit skin. Int. Immunol. 5:1993;681-690.
29. Hartman D.A., Ochalski S.J., Carlson R.P. The effects of antiinflammatory and antiallergic drugs on cytokine release after stimulation of human whole blood by lipopolysaccharide and zymosan A. Inflamm. Res. 44:1995;269-274.
30. Charreau B., Coupel S., Goret F.et al. Association of glucocorticoids and cyclosporin A or rapamycin prevents E-selectin and IL-8 expression during LPS- and TNF alpha-mediated endothelial cell activation. Transplantation. 69:2000;945-953.
31. Santos A.A., Scheltinga M.R., Lynch E.et al. Elaboration of interleukin 1-receptor antagonist is not attenuated by glucocorticoids after endotoxemia. Arch. Surg. 128:1993;138-143.
32. DeForge L.E., Kenney J.S., Jones M.L.et al. Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies. J. Immunol. 148:1992;2133-2141.
33. Oliver J.C., Bland L.A., Oettinger C.W.et al. Cytokine kinetics in an in vitro whole blood model following an endotoxin challenge. Lymphokine Cytokine Res. 12:1993;115-120.
34. Steube K.G., Meyer C., Drexler H.G. Multiple regulation of constitutive and induced interleukin 8 secretion in human myelomonocytic cell lines. Cytokine. 12:2000;1229-1236.
35. Lin G., Pearson A.E., Scamurra R.W.et al. Regulation of interleukin-8 expression in porcine alveolar macrophages by bacterial lipopolysaccharide. J. Biol. Chem. 269:1994;77-85.
36. Yancy H., Ayres S.A., Farrell D.E.et al. Differential cytokine mRNA expression in swine whole blood and PBMC cultures. Vet. Immunol. Immunopathol. 79:2001;41-52.
37. Trebichavsky I., Spichal I., Zahradnickova M.et al. Lipopolysaccharide induces inflammatory cytokines in the pig amnion. Vet. Immunol. Immunopathol. 87:2002;11-18.
38. Trebichavsky I., Spichal I., Splichalova A.et al. Systemic and local cytokine responses of young piglets to oral infection with Salmonella enterica serotype Typhimurium. Folia Microbiol. 2003;. [in press].
39. Pampusch M.S., Bennaars A.M., Harsch S.et al. Inducible nitric oxide synthase expression in porcine immune cells. Vet. Immunol. Immunopathol. 61:1998;279-290.
40. Hoebe K.H., Gonzalez-Ramon N., Nijmeijer S.M.et al. Differential effects of pentoxifylline on the hepatic inflammatory response in porcine liver cell cultures. Increase in inducible nitric oxide synthase expression. Biochem. Pharmacol. 61:2001;1137-1144.
41. Isobe M., Katsuramaki T., Hirata K.et al. Beneficial effects of inducible nitric oxide synthase inhibitor on reperfusion injury in the pig liver. Transplantation. 27:1999;803-813.
42. Mehta S., Javeshghani D., Datta P.et al. Porcine endotoxemic shock is associated with increased expired nitric oxide. Crit. Care Med. 27:1999;255-256.
43. Pastor C.M., Hadengue A., Nussler A.K. Minor involvement of nitric oxide curing chronic endotoxemia in anesthetized pigs. Am. J. Physiol.: Gasterointest. Liver Physiol. 278:2000;G416-G424.
44. Jorens P.G., Van Overveld F.J., Vermeire P.A.et al. Synergism between interleukin-1 beta and interferon-gamma, an inducer of nitric oxide synthase, in rat lung fibroblasts. Eur. J. Pharmacol. 224:1992;7-12.
45. Geller D.A., Nussler A.K., Di Silvio M., Lowenstein C.J., Shapiro R.A., Wang S.C.et al. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc. Natl. Acad. Sci. U. S. A. 90:1993;522-526.
46. Tracey W.R., Tse J., Carter G. Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J. Pharmacol. Exp. Ther. 272:1995;1011-1015.
47. Hattori Y., Akimoto K., Nakanishi N.et al. Glucocorticoid regulation of nitric oxide and tetrahydrobiopterin in a rat model of endotoxic shock. Biochem. Biophys. Res. Commun. 240:1997;298-303.
48. Kauser K., Sonnenberg D., Tse J.et al. 17 beta-estradiol attenuates endotoxin-induced excessive nitric oxide production in ovariectomized rats in vivo. Am. J. Physiol. 273(1 Pt. 2):1997;H506-H509.
49. Werner E.R., Werner-Felmayer G., Wachter H. Tetrahydrobiopterin and cytokines. Proc. Soc. Exp. Biol. Med. 203:1993;1-12.
50. Remick D.G., Strieter R.M., Lynch J.P. IIIet al. In vivo dynamics of murine tumor necrosis factor-alpha gene expression. Kinetics of dexamethasone-induced suppression. Lab. Invest. 60:1989;766-771.
51. Fretland D.J., Anglin C., Widomski D.et al. Temporal relationships of cytokine production in mouse non-lethal sepsis: effect of nitric oxide synthase inhibitors. Inflamm. Res. 46(Suppl. 2):1997;S155-S156.
52. Vedder H., Schreiber W., Yassouridis A.et al. Dose-dependence of bacterial lipopolysaccharide (LPS) effects on peak response and time course of the immune-endocrine host response in humans. Inflamm. Res. 48:1999;67-74.
53. Murphey E.D., Traber D.L. Pretreatment with tumor necrosis factor-alpha attenuates arterial hypotension and mortality induced by endotoxin in pigs. Crit. Care Med. 28:2000;2015-2021.
54. Emeis J.J., Hoekzema R., de Vos A.F. Inhibiting interleukin-1 and tumor necrosis factor-alpha does not reduce induction of plasminogen activator inhibitor type-1 by endotoxin in rats in vivo. Blood. 85:1995;115-120.
55. Ohtsuka H., Higuchi T., Matsuzawa H.et al. Inhibitory effect on LPS-induced tumor necrosis factor in calves treated with chlorpromazine or pentoxifylline. J. Vet. Med. Sci. 59:1997;1075-1077.
56. Kenison D.C., Elsasser T.H., Fayer R. Tumor necrosis factor as a potential mediator of acute metabolic and hormonal responses to endotoxemia in calves. Am. J. Vet. Res. 52:1991;1320-1326.
57. Allen G.K., Green E.M., Robinson J.A.et al. Serum tumor necrosis factor alpha concentrations and clinical abnormalities in colostrum-fed and colostrum-deprived neonatal foals given endotoxin. Am. J. Vet. Res. 54:1993;1404-1410.
58. Robinson J.A., Allen G.K., Green E.M.et al. Serum interleukin-6 concentrations in endotoxin-infused neonatal foals. Am. J. Vet. Res. 54:1993;1411-1414.
59. MacKay R.J., Merritt A.M., Zertuche J.-M.et al. Tumor necrosis factor activity in the circulation of horses given endotoxin. Am. J. Vet. Res. 52:1991;533-538.
60. Amoit F., Fitting C., Tracey K.J.et al. Lipopolysaccharide-induced cytokine cascade and lethality in LTα/TNFα-deficient mice. Mol. Med. 3:1997;864-875.
61. Standiford T.J., Strieter R.M., Lukacs N.W.et al. Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J. Immunol. 155:1995;2222-2229.
62. 2 with concomitant reduction of cytokine production. Infect. Immun. 63:1995;4812-4817.